Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HLA Antigens | 9 | 2022 | 546 | 1.660 |
Why?
|
| Transplantation | 2 | 2018 | 56 | 1.320 |
Why?
|
| Kidney Transplantation | 4 | 2022 | 755 | 1.170 |
Why?
|
| Graft Rejection | 8 | 2022 | 834 | 0.930 |
Why?
|
| Histocompatibility Testing | 3 | 2022 | 447 | 0.910 |
Why?
|
| Isoantibodies | 4 | 2022 | 115 | 0.820 |
Why?
|
| Chimerism | 1 | 2021 | 63 | 0.810 |
Why?
|
| Laboratories | 1 | 2022 | 145 | 0.770 |
Why?
|
| Organ Transplantation | 1 | 2021 | 191 | 0.680 |
Why?
|
| Tissue and Organ Procurement | 1 | 2021 | 233 | 0.660 |
Why?
|
| B7 Antigens | 1 | 2018 | 84 | 0.640 |
Why?
|
| Epitopes | 1 | 2018 | 685 | 0.550 |
Why?
|
| OX40 Ligand | 1 | 2015 | 28 | 0.540 |
Why?
|
| Histocompatibility Antigens Class I | 4 | 2008 | 235 | 0.470 |
Why?
|
| Protein Kinases | 2 | 2008 | 874 | 0.460 |
Why?
|
| Homozygote | 1 | 2015 | 717 | 0.450 |
Why?
|
| Cell Proliferation | 5 | 2010 | 7226 | 0.440 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2021 | 4549 | 0.440 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 2291 | 0.430 |
Why?
|
| Endothelial Cells | 3 | 2008 | 1048 | 0.400 |
Why?
|
| Endothelium, Vascular | 4 | 2008 | 891 | 0.370 |
Why?
|
| Cytokines | 1 | 2018 | 2809 | 0.350 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2008 | 460 | 0.340 |
Why?
|
| H-2 Antigens | 1 | 2008 | 42 | 0.320 |
Why?
|
| T-Lymphocytes | 4 | 2018 | 3869 | 0.320 |
Why?
|
| HLA-A Antigens | 1 | 2008 | 102 | 0.310 |
Why?
|
| Cell Survival | 4 | 2008 | 3045 | 0.310 |
Why?
|
| Signal Transduction | 5 | 2008 | 11965 | 0.290 |
Why?
|
| Integrins | 1 | 2008 | 262 | 0.280 |
Why?
|
| Heart Transplantation | 3 | 2010 | 908 | 0.260 |
Why?
|
| Kidney Glomerulus | 2 | 2017 | 156 | 0.250 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2010 | 986 | 0.250 |
Why?
|
| Hematologic Neoplasms | 1 | 2015 | 1870 | 0.240 |
Why?
|
| Primary Graft Dysfunction | 1 | 2023 | 34 | 0.230 |
Why?
|
| Neuromyelitis Optica | 1 | 2022 | 26 | 0.220 |
Why?
|
| Reperfusion Injury | 1 | 2023 | 145 | 0.210 |
Why?
|
| MicroRNAs | 2 | 2017 | 2947 | 0.200 |
Why?
|
| B-Lymphocytes | 2 | 2018 | 1294 | 0.200 |
Why?
|
| Microsatellite Repeats | 1 | 2021 | 575 | 0.180 |
Why?
|
| Lung Transplantation | 1 | 2023 | 359 | 0.170 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2018 | 184 | 0.160 |
Why?
|
| Serologic Tests | 1 | 2018 | 137 | 0.160 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 5159 | 0.160 |
Why?
|
| Immunoglobulin G | 1 | 2022 | 1021 | 0.160 |
Why?
|
| Capillaries | 1 | 2017 | 99 | 0.150 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2015 | 6550 | 0.150 |
Why?
|
| Tissue Donors | 1 | 2021 | 769 | 0.150 |
Why?
|
| Antibodies, Monoclonal | 2 | 2008 | 4367 | 0.150 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2018 | 203 | 0.150 |
Why?
|
| Mice, Inbred BALB C | 3 | 2010 | 2314 | 0.140 |
Why?
|
| Humans | 20 | 2023 | 261506 | 0.140 |
Why?
|
| Oncogene Proteins v-myb | 1 | 2015 | 8 | 0.140 |
Why?
|
| Blood Group Incompatibility | 1 | 2016 | 34 | 0.140 |
Why?
|
| ABO Blood-Group System | 1 | 2016 | 127 | 0.130 |
Why?
|
| Flow Cytometry | 1 | 2022 | 3033 | 0.130 |
Why?
|
| Autoantibodies | 1 | 2017 | 576 | 0.120 |
Why?
|
| End Stage Liver Disease | 1 | 2016 | 170 | 0.120 |
Why?
|
| Pleural Neoplasms | 1 | 2018 | 470 | 0.120 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 1538 | 0.110 |
Why?
|
| Mesothelioma | 1 | 2018 | 544 | 0.110 |
Why?
|
| Thrombotic Microangiopathies | 1 | 2013 | 70 | 0.110 |
Why?
|
| Computational Biology | 1 | 2018 | 1271 | 0.100 |
Why?
|
| Antigens, Neoplasm | 1 | 2018 | 1506 | 0.100 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2008 | 1546 | 0.100 |
Why?
|
| Transplantation Tolerance | 1 | 2010 | 15 | 0.090 |
Why?
|
| Isoantigens | 1 | 2010 | 62 | 0.090 |
Why?
|
| Antigens, CD | 1 | 2015 | 1385 | 0.090 |
Why?
|
| Genome-Wide Association Study | 1 | 2018 | 2265 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 3 | 2010 | 6942 | 0.090 |
Why?
|
| Transcriptome | 1 | 2018 | 1859 | 0.090 |
Why?
|
| Cells, Cultured | 2 | 2008 | 5637 | 0.090 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 2 | 2007 | 161 | 0.080 |
Why?
|
| Luciferases | 1 | 2010 | 445 | 0.080 |
Why?
|
| 3' Untranslated Regions | 1 | 2010 | 343 | 0.080 |
Why?
|
| Histocompatibility Antigen H-2D | 1 | 2008 | 5 | 0.080 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 694 | 0.080 |
Why?
|
| Focal Adhesions | 1 | 2007 | 45 | 0.080 |
Why?
|
| Immunization, Passive | 1 | 2008 | 172 | 0.070 |
Why?
|
| Algorithms | 1 | 2018 | 3890 | 0.070 |
Why?
|
| Liver Transplantation | 1 | 2016 | 1112 | 0.070 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2008 | 265 | 0.070 |
Why?
|
| Case-Control Studies | 1 | 2015 | 6100 | 0.070 |
Why?
|
| Multiprotein Complexes | 1 | 2008 | 395 | 0.070 |
Why?
|
| Survival Rate | 2 | 2016 | 12221 | 0.070 |
Why?
|
| Lymphocyte Activation | 1 | 2010 | 1688 | 0.060 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2010 | 1033 | 0.060 |
Why?
|
| Transfection | 1 | 2010 | 2944 | 0.060 |
Why?
|
| RNA, Small Interfering | 2 | 2008 | 2216 | 0.060 |
Why?
|
| Phosphorylation | 3 | 2008 | 4804 | 0.060 |
Why?
|
| Cell Line | 2 | 2010 | 5114 | 0.060 |
Why?
|
| Enzyme Activation | 1 | 2008 | 1764 | 0.060 |
Why?
|
| Blotting, Western | 1 | 2010 | 3536 | 0.060 |
Why?
|
| Transplantation, Homologous | 1 | 2010 | 2843 | 0.060 |
Why?
|
| MAP Kinase Signaling System | 1 | 2008 | 848 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 3639 | 0.060 |
Why?
|
| Disease-Free Survival | 1 | 2015 | 10001 | 0.060 |
Why?
|
| Infant | 2 | 2016 | 13310 | 0.060 |
Why?
|
| RNA, Messenger | 1 | 2013 | 6150 | 0.060 |
Why?
|
| Aquaporin 4 | 1 | 2022 | 15 | 0.060 |
Why?
|
| Treatment Outcome | 3 | 2018 | 32848 | 0.050 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2010 | 1586 | 0.050 |
Why?
|
| Child, Preschool | 2 | 2016 | 16273 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 8873 | 0.050 |
Why?
|
| Potassium Channels | 1 | 2022 | 162 | 0.050 |
Why?
|
| Antibodies | 1 | 2004 | 838 | 0.050 |
Why?
|
| Haplotypes | 1 | 2022 | 856 | 0.050 |
Why?
|
| Mice, Transgenic | 1 | 2008 | 4143 | 0.050 |
Why?
|
| Benzimidazoles | 1 | 2003 | 428 | 0.050 |
Why?
|
| Mice | 3 | 2010 | 34495 | 0.040 |
Why?
|
| Lung | 2 | 2023 | 3151 | 0.040 |
Why?
|
| Proteins | 1 | 2008 | 1963 | 0.040 |
Why?
|
| Pyrroles | 1 | 2003 | 576 | 0.040 |
Why?
|
| Costimulatory and Inhibitory T-Cell Receptors | 1 | 2018 | 19 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2008 | 5710 | 0.040 |
Why?
|
| Male | 5 | 2017 | 123000 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2004 | 1493 | 0.040 |
Why?
|
| Child | 2 | 2016 | 29154 | 0.040 |
Why?
|
| Research Report | 1 | 2018 | 144 | 0.040 |
Why?
|
| Proteogenomics | 1 | 2018 | 87 | 0.040 |
Why?
|
| Female | 5 | 2017 | 141928 | 0.040 |
Why?
|
| Pleura | 1 | 2018 | 127 | 0.040 |
Why?
|
| Animals | 4 | 2010 | 59536 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2018 | 6207 | 0.040 |
Why?
|
| Aged | 3 | 2017 | 70117 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2018 | 702 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2018 | 11538 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2017 | 1618 | 0.030 |
Why?
|
| Adult | 3 | 2017 | 77950 | 0.030 |
Why?
|
| DNA | 1 | 2003 | 2693 | 0.030 |
Why?
|
| Adolescent | 1 | 2015 | 31252 | 0.030 |
Why?
|
| Single-Cell Analysis | 1 | 2018 | 470 | 0.030 |
Why?
|
| Middle Aged | 3 | 2017 | 86204 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2008 | 5270 | 0.030 |
Why?
|
| ADAMTS13 Protein | 1 | 2013 | 92 | 0.030 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2013 | 65 | 0.030 |
Why?
|
| Calcineurin Inhibitors | 1 | 2013 | 68 | 0.030 |
Why?
|
| src-Family Kinases | 2 | 2007 | 478 | 0.030 |
Why?
|
| ADAM Proteins | 1 | 2013 | 134 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2022 | 37905 | 0.030 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2013 | 163 | 0.030 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2013 | 270 | 0.020 |
Why?
|
| Mice, Inbred CBA | 1 | 2010 | 78 | 0.020 |
Why?
|
| Whole-Body Irradiation | 1 | 2010 | 307 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2007 | 1678 | 0.020 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2018 | 1249 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2007 | 2054 | 0.020 |
Why?
|
| Adoptive Transfer | 1 | 2010 | 446 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2018 | 2864 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 4988 | 0.020 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2007 | 153 | 0.020 |
Why?
|
| Age Factors | 1 | 2016 | 5377 | 0.020 |
Why?
|
| Risk Factors | 1 | 2023 | 17523 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2010 | 778 | 0.020 |
Why?
|
| bcl-Associated Death Protein | 1 | 2004 | 26 | 0.020 |
Why?
|
| Actins | 1 | 2007 | 608 | 0.020 |
Why?
|
| Titrimetry | 1 | 2003 | 10 | 0.010 |
Why?
|
| Hydroxybutyrates | 1 | 2003 | 44 | 0.010 |
Why?
|
| bcl-X Protein | 1 | 2004 | 196 | 0.010 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2004 | 111 | 0.010 |
Why?
|
| Fluorometry | 1 | 2003 | 34 | 0.010 |
Why?
|
| Androstadienes | 1 | 2004 | 165 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2018 | 12873 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 2003 | 153 | 0.010 |
Why?
|
| RNA Interference | 1 | 2007 | 1408 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2018 | 14551 | 0.010 |
Why?
|
| Nucleic Acid Conformation | 1 | 2003 | 279 | 0.010 |
Why?
|
| Graft Survival | 1 | 2005 | 1062 | 0.010 |
Why?
|
| Kinetics | 1 | 2003 | 2049 | 0.010 |
Why?
|
| Prognosis | 1 | 2018 | 21713 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2010 | 4053 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2004 | 2450 | 0.010 |
Why?
|
| Imidazoles | 1 | 2003 | 999 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2004 | 1756 | 0.010 |
Why?
|
| Time Factors | 1 | 2010 | 12926 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2004 | 2022 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2004 | 2488 | 0.010 |
Why?
|